5-Diagnostics and DSM Pentapharm Announce Global Distribution Partnership
BASEL, Switzerland, March 10, 2016 /PRNewswire/ --
Effective March 1, 2016, 5-Diagnostics, a sales and marketing specialist in hemostasis diagnostics will serve as a global distributor of DSM Pentapharm. The new agreement aims at strengthening market access in specialized hemostasis diagnostics. The two companies also enter into an alliance to complement DSM Pentapharm's strategic focus on hemostasis and join forces to bring innovative, high quality hemostasis products and services to customers.
(Logo: http://photos.prnewswire.com/prnh/20160309/342480LOGO )
Following the discontinuation of agreements with current DSM Pentapharm distributors, 5-Diagnostics will globally market DSM Pentapharm's diagnostic product range to hospitals, research organizations and laboratories. DSM Pentapharm will continue to directly serve its customers in the diagnostic industry (manufacturers of diagnostic products and solutions).
Marc Wittwer, International Sales Manager of 5-Diagnostics adds: "DSM Pentapharm's renowned brand in hemostasis coupled with 5-Diagnostics' global sales network and reach to customers will drive further sales and access to DSM Pentapharm products. We are very pleased to ally with DSM Pentapharm to develop kits and reagents for research and clinical use which respond perfectly to customer needs. I believe that our partnership results in a real win-win for researchers, health care professionals and patients worldwide."
"Based on 5-Diagnostics' considerable expertise and experience in serving the needs of the hemostasis research and clinical community, the company fully embraces our goal of bringing our hemostasis portfolio to customers proficiently, across relevant segments and territories. The alliance will reinforce our R&D cycle, from the definition of new products and requirements to the execution of performance evaluation studies. We ally with 5-Diagnostics to drive a timely launch of valuable products to customers at a reasonable price", states Peter Lugosi , General Manager of DSM Pentapharm.
About 5-Diagnostics Ltd
Based in Basel, Switzerland, 5-Diagnostics is the new name in global specialized hemostasis distribution. 5-Diagnostics employs a centrally managed, global network of dedicated hemostasis sales representatives and product specialists, with proven expertise to meet the needs of individual customer segments, ranging from industry to research labs to clinical customers.
5-Diagnostics offers best in class customer service providing a sophisticated web shop and product information system. Customer support is focused on enquiry and complaint resolution efficiency, backed up by an established network of renowned and ISO/FDA registered manufacturers and collaborations with scientific and medical experts. For more information, visit: http://www.5-diagnostics.com
About DSM Pentapharm
Pentapharm has been a member of the DSM group since 2007. Since its inception near Basel, Switzerland, in 1947 it has focused on specialized coagulation. DSM Pentapharm manufactures high-quality diagnostics kits, such as the well-known Pefakit® APC-R, the Pefakit PiCT® or the Pefakit TAFI activity test. The company also offers various reagents (from research to bulk quantities, including custom manufacturing) such as chromogenic, fluorogenic and amperogenic peptide substrates, protease inhibitors and snake venom enzymes, as well as synthesis of peptides and small organic molecules. Besides Diagnostics, DSM Pentapharm also produces active pharmaceutical ingredients such as aprotinin, peptides and snake venom derived enzymes.
For more information:
SOURCE 5-Diagnostics Ltd.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article